跳至主要内容
临床试验/NCT03960749
NCT03960749已完成不适用

The Importance of Needle Size, Needle Design and Stylet Reinsertion to Prevent Post-lumbar Puncture Headache, a Randomized Controlled Trial

Jonatan Salzer0 个研究点目标入组 1,000 人开始时间: 2013年5月28日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
1,000
主要终点
Odds ratio for post-lumbar puncture headache (any)

研究概览

简要总结

The objectives of this study are to investigate the effects of needle design, needle size and stylet reinsertion on the risk for headache after diagnostic LP (lumbar puncture, Post-LP headache). The following needles are used in the study:

  1. Sprotte 25 Gauge (G) (0.5 mm) atraumatic needle with introducer
  2. Sprotte 22 G (0.7 mm) atraumatic needle with introducer
  3. Spinocan 25 G (0.5 mm) cutting needle

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
Double (Participant, Outcomes Assessor)

盲法说明

The participants are not informed about the allocated needle. The follow-up telephone calls (outcome assessment) are made by an assistant nurse who is unaware of randomization allocation.

入排标准

年龄范围
16 Years 至 —(Child, Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Subjects undergoing diagnostic LP during their neurological work-up at Umeå University Hospital, Sweden, from 28 May 2013 until the study is fully recruited and;
  • Willing to participate and
  • Providing informed consent

排除标准

  • Subjects unable to participate in the study follow-up

研究组 & 干预措施

Sprotte 25G needle, stylet reinserted

Experimental

干预措施: Sprotte 25G needle, stylet reinserted (Device)

Sprotte 25G needle, stylet not reinserted

Experimental

干预措施: Sprotte 25G needle, stylet not reinserted (Device)

Sprotte 22G needle, stylet reinserted

Experimental

干预措施: Sprotte 22G needle, stylet reinserted (Device)

Sprotte 22G needle, stylet not reinserted

Experimental

干预措施: Sprotte 22G needle, stylet not reinserted (Device)

Spinocan 25G needle, stylet reinserted

Experimental

干预措施: Spinocan 25G needle, stylet reinserted (Device)

Spinocan 25G needle, stylet not reinserted

Experimental

干预措施: Spinocan 25G needle, stylet not reinserted (Device)

结局指标

主要结局

Odds ratio for post-lumbar puncture headache (any)

时间窗: Up to 14 days after LP

Any post-lumbar puncture headache (as defined in the international classification of headache disorders 3 (ICHD-3).

次要结局

  • Odds ratio for post-lumbar puncture headache (severe)(Up to 14 days after LP)
  • Headache duration (days)(Until cessation, up to 14 days after LP)
  • Proportion using analgesia(During post-lumbar puncture headache, up to 14 days after LP)
  • Proportion with back pain(Up to 14 days after LP)
  • Proportion on sick leave(During post-lumbar puncture headache, up to 14 days after LP)
  • Proportion with radiating leg pain(Up to 14 days after LP)
  • Multiplicative interactions between age (years), sex, BMI and needle visavi the outcome "any post-LP headache" in a multivariable logistic regression model(Up to 14 days after LP)

研究者

发起方
Jonatan Salzer
申办方类型
Other Gov
责任方
Sponsor Investigator
主要研究者

Jonatan Salzer

Principal Investigator

Region Västerbotten

相似试验